NASDAQ Stockholm: ONCO

How many employees work at Oncopeptides?

Oncopeptides AB (ONCO) has approximately 75 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Oncopeptides’s total headcount has grown 16.2% from 64 employees in 2023 to 75 in 2026.

Data source: Revelio LabsCoverage: Global workforce, 20232026Published August 2026

Is Oncopeptides hiring right now?

No, Oncopeptides is not actively hiring. Oncopeptides had 0 active job postings in 2026, a 0.0% no change from 2025 see job openings & hiring trends.

About Oncopeptides’s Workforce

Oncopeptides AB (ONCO) is a Pharmaceuticals company that employs 75 people worldwide as of March 2026. It is the 7th-largest by headcount among its peers. Founded in 2000, the company is headquartered in Stockholm, Sweden and trades on the NASDAQ Stockholm.

Oncopeptides's workforce has grown 16.2% from 2023 to 2026, up 10.2% year over year in 2026. Its workforce is concentrated most in Northern Europe (59.9%), followed by Southern Europe (22.0%) and Western Europe (13.8%).

Oncopeptides's functional groups are Finance and Operations (44.3%), Sales and Marketing (33.3%), and Engineering (22.4%), with Finance and Operations growing fastest (up 13.5%). The average salary is $128,521, ranging from a median of $162,000 in Western Europe to $74,000 in Southern Europe, down 5.2% year over year in 2026.

Oncopeptides's hiring activity held steady in 2026. Overall employee sentiment is neutral but declining.

Sourced from Revelio Labs workforce data.

Ticker
NASDAQ Stockholm: ONCO
Headquarters
Stockholm, Sweden
Founded
2000
Industry
Pharmaceuticals
Employees
75
YoY
+10.2% (+9)

Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Oncopeptides. Compare to peers, export the dataset, and access the full quarterly history.

Unlock Metrics

Oncopeptides Annual Employee Count (2023-2026)

Interactive chart of Oncopeptides annual worldwide employee count from 2023 to 2026.
  • Oncopeptides had 75 employees in 2026, a 10.2% increase (+9) from 2025.
  • Oncopeptides had 75 employees in 2025, a 5.9% increase (+1) from 2024.
  • Oncopeptides had 74 employees in 2024, a 2.6% decline (+7) from 2023.
  • Oncopeptides had 67 employees in 2023, a 7.6% increase (+11) from 2022.

Oncopeptides's total workforce has grown from 64 employees in 2023 to 75 in 2026.

Oncopeptides AB quarterly employee count

YearQtrEmployeesYoY ChangeYoY %
2026Q175+9+10.2%
2025Q475+1+5.9%
2025Q371-7-1.6%
2025Q269-3-5.2%
2025Q166-7-10.7%
2024Q474+7-2.6%
2024Q378+14+1.8%
2024Q272+8+3.7%
2024Q173+13+10.2%
2023Q467+11+7.6%
2023Q364+16+9.9%
2023Q264+14+8.1%

See Oncopeptides's complete headcount history, including quarterly breakdowns.

Get the Data

Oncopeptides Employee Count by Region (2026)

Northern Europe accounts for the largest share of Oncopeptides's global workforce with approximately 60% of total employees, followed by Southern Europe and Western Europe.

Oncopeptides employees by region

RegionEmployees% of Total
Northern Europe4159.9%
Southern Europe1522.0%
Western Europe913.8%
North America11.8%
South Asia11.3%
North Africa11.2%

Drill into city-level data, hiring trends by region, and historic geographic shifts.

Unlock Geographic Data

Oncopeptides Employee Count by Department (2026)

Oncopeptides's employee groups are Finance and Operations (44.3%), Sales and Marketing (33.3%), and Engineering (22.4%).

Oncopeptides employees by department

DepartmentEmployees% of Total
Finance and Operations3344.3%
Sales and Marketing2533.3%
Engineering1722.4%

Compare Oncopeptides's department mix to industry peers.

See Full Data

Oncopeptides Employee Salary by Region (2026)

Oncopeptides's average employee salary is $128,521 globally. Employees in Western Europe receive the highest compensation, with median pay approximately 1.3x the global average. Pay is lowest in Southern Europe, at a median of $74,000.

Oncopeptides median employee salary by region (USD)

RegionMedian Salary
Western Europe$162,000
Northern Europe$140,000
Southern Europe$74,000

Unlock salary by role, level, and city — and compare to Oncopeptides's industry peers.

Unlock Salary Data

Oncopeptides Job Openings and Hiring Trends (2023-2026)

Interactive chart of Oncopeptides annual active job postings from 2023 to 2026.
  • Oncopeptides had 0 active job postings in 2026, a 0% no change (-2) from 2025.
  • Oncopeptides had 2 active job postings in 2025, a 200.0% increase (+2) from 2024.
  • Oncopeptides had 0 active job postings in 2024, a 0% no change from 2023.
  • Oncopeptides had 0 active job postings in 2023, a 0% no change from 2022.
  • Hiring velocity in 2026: 0 new roles/month, down from 1 in 2025 and 0 in 2024.

Oncopeptides's hiring activity held steady in 2026.

Track new postings per month, role-level demand, and hiring velocity vs. peers.

Unlock Hiring Data

Oncopeptides Employee Sentiment (2026)

Revelio Labs tracks employee sentiment across Oncopeptides's workforce based on public professional data. Overall sentiment is neutral and has declined year over year in 2026.

Overall

NegativePositive

Unlock the full sentiment breakdown by department, tenure, and trend over time.

Unlock Sentiment

Similar Companies

Frequently Asked Questions About Oncopeptides

How fast is Oncopeptides growing?
In 2026, Oncopeptides's headcount grew 10.2% to 75 employees, up from 66 in 2025.
See the full headcount history
Where are Oncopeptides employees located?
Most Oncopeptides employees are based in Northern Europe (59.9% of headcount), followed by Southern Europe and Western Europe.
Explore where the workforce is based
What is the average salary at Oncopeptides?
The average employee salary at Oncopeptides is approximately $128.5k per year.
Analyze the salary distribution
How many new job postings does Oncopeptides open per year?
In Q1 2026, Oncopeptides opened 0 new job postings. In 2025, Oncopeptides opened 7 new job postings — about 1 per month.
Track hiring trends by role
When was Oncopeptides founded and where is it headquartered?
Oncopeptides was founded in 2000 and is headquartered in Stockholm, Sweden.
Compare Oncopeptides to industry peers

Speak with a workforce expert about Oncopeptides.

Book a Demo

See something that doesn't look right? Reach out and our team will review it.